Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 33, 2018 - Issue 1
Related Research Data
A crystal structure-guided rational design switching non-carbohydrate inhibitors' specificity between two β-GlcNAcase homologs
Source:
Nature Publishing Group
Comparative biochemistry of GH3, GH20 and GH84 β-N-acetyl-Dhexosaminidases and recent progress in selective inhibitor discovery
Source:
Bentham Science Publishers Ltd.
Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human β-N-Acetyl-d-hexosaminidase
Source:
American Chemical Society (ACS)
Identification of novel insect β-N-acetylhexosaminidase OfHex1 inhibitors based on virtual screening, biological evaluation, and molecular dynamics simulation.
Source:
Taylor & Francis
The structure of nagstatin, a new inhibitor of N-acetyl-beta-D-glucosaminidase.
Source:
Japan Antibiotics Research Association
Screening libraries for hexosaminidase enhancers
Source:
Wiley
Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis
Source:
Elsevier BV
Structural characterization of human CRTh2: a combined homology modeling, molecular docking and 3D-QSAR-based in silico approach
Source:
Springer Science and Business Media LLC
Computational insight into the structure-activity relationship of novel N-substituted phthalimides with gibberellin-like activity.
Source:
Springer Science and Business Media LLC
Structural and sequence-based classification of glycoside hydrolases.
Source:
Elsevier BV
Exploring unsymmetrical dyads as efficient inhibitors against the insect β-N-acetyl-D-hexosaminidase OfHex2.
Source:
Elsevier BV
Novel naphthalimide–aminobenzamide dyads as OFF/ON fluorescent supramolecular receptors in metal ion binding
Source:
Taylor & Francis
NAG-thiazoline, An N-Acetyl-β-hexosaminidase Inhibitor That Implicates Acetamido Participation
Source:
American Chemical Society (ACS)
Design and synthesis of naphthalimide group-bearing thioglycosides as novel β-N-acetylhexosaminidases inhibitors
Source:
Taylor & Francis
Synthesis of the enantiomers of XYLNAc and LYXNAc: comparison of β-N-acetylhexosaminidase inhibition by the 8 stereoisomers of 2-N-acetylamino-1,2,4-trideoxy-1,4-iminopentitols
Source:
Royal Society of Chemistry (RSC)
Biochemical consequences of mutations causing the GM2 gangliosidoses.
Source:
Elsevier BV
Crystal Structure of β-Hexosaminidase B in Complex with Pyrimethamine, a Potential Pharmacological Chaperone
Source:
American Chemical Society (ACS)
Linking provided by
